1321.5000 -15.60 (-1.17%)
NSE Nov 19, 2026 15:29 PM
Volume: 37,385
 

logo
Eris Lifesciences Ltd.
19 May 2025, 12:00AM
1321.50
-1.17%
Motilal Oswal
Eris Lifesciences (ERIS) posted lower-than-expected 4QFY25 performance. This has been largely due to a marginal slip in the execution, particularly in the insulin revenue.
Promoters pledged 4.40% of shares in last quarter. Total pledge stands at 21.25% of promoter holdings
More from Eris Lifesciences…
All earning calls
Investor presentations from Eris Lifesciences…
All investor presentations